跳至主要内容
临床试验/NCT01971762
NCT01971762已完成不适用

Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology

Fundación Pública Andaluza Progreso y Salud16 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
600
试验地点
16
主要终点
The overall target is to assess if the implementation of an active intervention program improves clinical management of the disease, according to existing recommendations.

研究概览

简要总结

Staphylococcus aureus bacteremia: impact of an intervention program in improving the clinical management and review of the clinical and molecular epidemiology.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients over 14
  • •Clinical significant bacteremia by S. aureus
  • •Patient hospitalized

排除标准

  • •Non clinical significant bacteremia
  • •Ambulatory patient
  • •End-of-life patients

结局指标

主要结局

The overall target is to assess if the implementation of an active intervention program improves clinical management of the disease, according to existing recommendations.

时间窗: 6 months

Identify evidence-based quality-of-care indicators (QCIs) for the management of Staphylococcus aureus bacteremia (SAB). See secondary objective for the definitions of QCIs

次要结局

  • Follow-up blood cultures performance of control blood culture 48-96h.(6 months)
  • Early use of IV cloxacillin for meticillin susceptible Staphylococcus aureus as definitive therapy(6 months)
  • Early source control(6 months)
  • Adjustment of vancomycin dose according to trough levels.(6 months)
  • Echocardiography in patients with clinical indications(6 months)
  • Treatment duration according to the complexity of infection.(6 Months)

研究者

发起方
Fundación Pública Andaluza Progreso y Salud
申办方类型
Other
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验

Staphylococcus Aureus Bacteremia: Impact of an... | 临床试验